Cassidy Blundell
Directeur/Bestuurslid bij Arase Therapeutics, Inc.
Profiel
Cassidy Blundell is currently working as a Principal at BioInnovation Management LLC and is also a Board Member at Arase Therapeutics, Inc. She holds a doctorate degree from the University of Pennsylvania, which she received in 2018, and a graduate degree from Boston University, which she received in 2012.
Actieve functies van Cassidy Blundell
| Bedrijven | Functie | Begin |
|---|---|---|
Arase Therapeutics, Inc.
 Arase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arase Therapeutics, Inc. is a science-focused oncology company located in Cambridge, MA. The company is developing first-in-class therapeutics targeting adp-ribose hydrolases, novel targets that function therapeutically. The company's leadership includes scientists and founders Paul Chang, Ph.D., W. Lee Kraus, Ph.D., and Michael Taylor, Ph.D. The company's mission is supported by Biocapital, a founding investor, and the board is led by Paul Chang, Ph.D., who serves as the President, CEO/CSO, and lead founder. Cassidy Blundell, Ph.D., a principal at Mission Biocapital, and W. Lee Kraus, Ph.D., a scientific founder, also serve on the board. | Directeur/Bestuurslid | - |
BioInnovation Management LLC
 BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01-09-2021 |
Opleiding van Cassidy Blundell
| University of Pennsylvania | Doctorate Degree |
| Boston University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
BioInnovation Management LLC
BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Arase Therapeutics, Inc.
Arase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arase Therapeutics, Inc. is a science-focused oncology company located in Cambridge, MA. The company is developing first-in-class therapeutics targeting adp-ribose hydrolases, novel targets that function therapeutically. The company's leadership includes scientists and founders Paul Chang, Ph.D., W. Lee Kraus, Ph.D., and Michael Taylor, Ph.D. The company's mission is supported by Biocapital, a founding investor, and the board is led by Paul Chang, Ph.D., who serves as the President, CEO/CSO, and lead founder. Cassidy Blundell, Ph.D., a principal at Mission Biocapital, and W. Lee Kraus, Ph.D., a scientific founder, also serve on the board. | Health Technology |
